Series A - Yanming Biology
Investment Firm
Overview
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Announced Date
May 24, 2024
Funding Type
Series A
Highlights
N/A
Location
Asia
Social
Participant Investors
5
Round Details and Background
Yanming Biology raised an undisclosed amount on 2024-05-24 in Series A
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 10, 2023 |  Series A - Yanming Biology | 12 | - | 96.8M |
| May 24, 2024 | Series A - Yanming Biology | 8 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.